Date of birth
21.08.1988
Positions
Research work
Performance
Performance
2023
-
Shaimardanova A.A, Solovyeva V.V, Issa S.S, Gene Therapy of Sphingolipid Metabolic Disorders//International Journal of Molecular Sciences. - 2023. - Vol.24, Is.4. - Art. №3627.
-
Issa S.S, Shaimardanova A.A, Solovyeva V.V, Various AAV Serotypes and Their Applications in Gene Therapy: An Overview//Cells. - 2023. - Vol.12, Is.5. - Art. №785.
- Filin Ivan Y. Y., Mayasin Yuri P. P., Kharisova Chulpan B. B., Cell Immunotherapy against Melanoma: Clinical Trials Review//INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - 2023. - Vol.24, Is.3. - Art. №2413.
- Chulpanova Daria S., Pukhalskaia Tamara V., Gilazieva Zarema E., Cytochalasin B-Induced Membrane Vesicles from TRAIL-Overexpressing Mesenchymal Stem Cells Induce Extrinsic Pathway of Apoptosis in Breast Cancer Mouse Model//CURRENT ISSUES IN MOLECULAR BIOLOGY. - 2023. - Vol.45, Is.1. - P.571-592.
- Chulpanova Daria S., Rizvanov Albert A., Solovyeva Valeriya V., The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity//INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - 2023. - Vol.24, Is.1. - Art. №395.
-
Filin I.Y, Mayasin Y.P, Kharisova C.B, T-Lymphocytes Activated by Dendritic Cells Loaded by Tumor-Derived Vesicles Decrease Viability of Melanoma Cells In Vitro//Current Issues in Molecular Biology. - 2023. - Vol.45, Is.10. - P.7827-7841.
- Ponomarev Aleksei S., Gilazieva Zarema E., Solovyova Valeriya V., Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids//BIOCHEMISTRY-MOSCOW. - 2023. - Vol.88, Is.7 (SI). - P.979-997.
-
Gamirova R.G, Shaymardanova A.A, Barkov A.Yu, Treatment of epilepsy with mesenchymal stem cells: literature review« //Russkii Zhunal Detskoi Nevrologii. - 2023. - Vol.18, Is.1. - P.38-45.
-
Ponomarev A.S, Chulpanova D.S, Yanygina L.M, Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape//International Journal of Molecular Sciences. - 2023. - Vol.24, Is.18. - Art. №13743.
-
Ponomarev A.S, Gilazieva Z.E, Solovyova V.V, Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids//Biochemistry (Moscow). - 2023. - Vol.88, Is.7. - P.979-994.
-
Gorodilova A.V, Kitaeva K.V, Filin I.Y, The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment//Current Issues in Molecular Biology. - 2023. - Vol.45, Is.10. - P.8053-8070.
-
Mullagulova A, Shaimardanova A, Solovyeva V, Safety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs//International Journal of Molecular Sciences. - 2023. - Vol.24, Is.11. - Art. №9204.
2022
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, Functionality of a bicistronic construction containing HEXA and HEXB genes encoding ?-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses//Neural Regeneration Research. - 2022. - Vol.17, Is.1. - P.122-129.
- Ponomarev Aleksei, Kurnenkova Anna, Gilazieva Zarema, Evaluation of viability, cytokine profile changes and pluripotency genes of colorectal cancer spheroids cells after interaction with tumor and stem vesicles//CELL DEATH DISCOVERY. - 2022. - Vol.8, Is.1. - P.4-4.
-
Ponomarev A, Gilazieva Z, Solovyeva V, Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression//Cancers. - 2022. - Vol.14, Is.4. - Art. №970.
-
Solovyeva V.V, Kitaeva K.V, Chulpanova D.S, Analysis of the Interaction of Human Neuroblastoma Cell-Derived Cytochalasin B Induced Membrane Vesicles with Mesenchymal Stem Cells Using Imaging Flow Cytometry//BioNanoScience. - 2022. - Vol., Is.. - .
-
Chulpanova D.S, Shaimardanova A.A, Ponomarev A.S, Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis//International Journal of Molecular Sciences. - 2022. - Vol.23, Is.5. - Art. №2506.
-
Chulpanova D.S, Tazetdinova L.G, Arkhipova S.S, In Vivo Visualization of Stable Neuroblastoma Cell Lines with Overexpression of Firefly Luciferase or Far-Red Fluorescent Protein//BioNanoScience. - 2022. - Vol., Is.. - .
-
Issa S.S, Shaimardanova A.A, Valiullin V.V, Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders//Frontiers in Pharmacology. - 2022. - Vol.13, Is.. - Art. №859516.
- Препарат для лечения метахроматической лейкодистрофии / А.И. Муллагулова, А.А. Шаймарданова, Д.С. Чулпанова, В.В. Соловьева, Я.О. Мухамедшина, А.А. Костенников, А.А. Ризванов // Заявке на изобретение № 2021115696/10(033131). Дата приоритета: 01.06.2021
-
Tay-Sachs disease and Sandhoff disease are severe hereditary neurodegenerative disorders caused by a deficiency of β-hexosaminidase A (HexA) enzyme, which results in the accumulation of GM2 gangliosides in the nervous system cells. In this work, we analyzed the efficacy and safety of cell-mediated gene therapy for Sandhoff disease and Sandhoff disease using a bicistronic lentiviral vector encoding cDNA of HexA α- and β-subunit genes separated by the nucleotide sequence of a P2A peptide (HEXA-HEXB). The functionality of the bicistronic construct containing the HEXA-HEXB genetic cassette was analyzed in a culture of HEK293T cells and human umbilical cord blood mononuclear cells (hUCBMCs). Our results showed that the enzymatic activity of HexA in the conditioned medium harvested from genetically modified HEK293T-HEXA-HEXB and hUCBMCs-HEXA-HEXB was increased by 23 and 8 times, respectively, compared with the conditioned medium of native cells. Western blot analysis showed that hUCBMCs-HEXA
NRR_17_122.pdf -
Chulpanova D.S, Pukhalskaia T.V, Rizvanov A.A, Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells//Bioengineering. - 2022. - Vol.9, Is.6. - Art. №245.
-
Shaimardanova A.A, Chulpanova D.S, Mullagulova A.I, Gene and Cell Therapy for Epilepsy: A Mini Review//Frontiers in Molecular Neuroscience. - 2022. - Vol.15, Is.. - Art. №868531.
-
Gilazieva Z, Ponomarev A, Rizvanov A, The Dual Role of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Carcinogenesis//Biology. - 2022. - Vol.11, Is.6. - Art. №813.
- Shaimardanova A, Mullagulova A, Issa S, A study of vector immunity formation and gene therapy effectiveness based on adeno-associated viruses//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Mullagulova A, Shaimardanova A, Issa S, Analysis of functionality and biodistribution of AAV/Olig001 encoding arylsulfatase a gene in the porcine nervous system//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Filin I, Kitaeva K, Chulpanova D, Analysis of immune cell activation after interaction with membrane vesicles from genetically modified tumor cells//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Shaimardanova A, Chulpanova D, Issa S, Cross-correction of beta-hexosaminidase a deficiency using genetically modified human mesenchymal stem cells in a cell culture of tay-sachs disease patient//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Chulpanova D, Pukhalskaia T, Rizvanov A, Cytochalasin B-induced membrane vesicles from mesenchymal stem cells overexpressing TRAIL activate key components of the apoptotic pathway in breast cancer mouse model//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Shaimardanova AA, Chulpanova DS, Solovyeva VV, Functionality of a bicistronic construction containing HEXA and HEXB genes encoding beta-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses//NEURAL REGENERATION RESEARCH. - 2022. - Vol.17, Is.1. - P.122-129.
- Ponomarev A, Gilazieva Z, Rizvanov A, The study of colonosphere formation after the addition of cytochalasin B induced membrane vesicles//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Gilazieva Z, Ponomarev A, Chulpanova D, The study of tumor spheroids formation after cytochalasin B induced membrane vesicles addition//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Shaimardanova A. Generation and functional analysis of plasmid DNA encoding beta-hexosaminidase gene for Tay-Sachs disease therapy / A. Shaimardanova, D. Chulpanova, V. Solovyeva, A. Rizvanov // HUMAN GENE THERAPY. – 2019. – Vol. 30(11), P. A155-A156 (Impact Factor = 4,51). Q1
- Gilazieva Z , Chulpanova D , Ponomarev A , Comparative Analysis of Natural and Cytochalasin B-Induced Membrane Vesicles from Tumor Cells and Mesenchymal Stem Cells//CURRENT ISSUES IN MOLECULAR BIOLOGY. - 2022. - Vol.44, Is.11. - P.5363-5378.
-
Kitaeva K.V, Chulpanova D.S, Zhuravleva M.N, Characteristics and Resistance to Cisplatin of Human Neuroblastoma Cells Co-Cultivated with Immune and Stromal Cells//Bioengineering. - 2022. - Vol.9, Is.11. - Art. №655.
-
Filin I.Y, Kitaeva K.V, Chulpanova D.S, Tumor-Derived Membrane Vesicles from the IL-2 Overexpression Melanoma Cells Affect on the Expression of Surface Markers of Human Peripheral Blood Mononuclear Cells In Vitro//BioNanoScience. - 2022. - Vol., Is.. - .
-
Kitaeva K, Kiyasov A, Rizvanov A, Stem cells, fitness, and aging//Aging: From Fundamental Biology to Societal Impact. - 2022. - Vol., Is.. - P.385-405.
- Filin I. Yu., Kitaeva K. V., Rizvanov A. A., Current State and Prospects of Using Dendritic Cell Vaccination for Cancer Immunotherapy//UCHENYE ZAPISKI KAZANSKOGO UNIVERSITETA-SERIYA ESTESTVENNYE NAUKI. - 2022. - Vol.164, Is.3. - P.347-366.
- Filin Ivan, Kitaeva Kristina, Gorodilova Anna, Evaluation of immune cell cytotoxic activity after interaction with tumour-derived membrane vesicles//CELL DEATH DISCOVERY. - 2022. - Vol.8, Is.1. - P.1-2.
-
Vrana N.E, Gupta S, Mitra K, From 3D printing to 3D bioprinting: the material properties of polymeric material and its derived bioink for achieving tissue specific architectures//Cell and Tissue Banking. - 2022. - Vol., Is.. - .
2021
-
Chulpanova D.S, Gilazieva Z.E, Kletukhina S.K, Cytochalasin B-Induced membrane vesicles from human mesenchymal stem cells overexpressing IL2 are able to stimulate CD8+ T-Killers to kill human triple negative breast cancer cells//Biology. - 2021. - Vol.10, Is.2. - P.1-32.
-
Способ терапии болезни Тея-Сакса и болезни Сандхоффа с помощью генетически модифицированных мезенхимных стволовых клеток человека со сверхэкспрессией β-гексозаминидазы A: Пат. 2748383 Российская Федерация, МПК A61K 35/28, A61K 48/00, A61P 3/00. Патентообладатель Казанский (Приволжский) федеральный университет. Авторы: А.А. Шаймарданова, Д.С. Чулпанова, В.В. Соловьева, А.А. Ризванов. Заявка на патент на изобретение № 2020134611/14(063518). Дата подачи заявки 21.10.2020; опубл. 25.05.2021.
Patent_2021.pdf -
Gatina D.Z, Garanina E.E, Zhuravleva M.N, Proangiogenic effect of 2A-peptide based multicistronic recombinant constructs encoding VEGF and FGF2 growth factors//International Journal of Molecular Sciences. - 2021. - Vol.22, Is.11. - Art. № 5922.
- Shaimardanova A., Chulpanova D., Solovyeva V., Development and analysis of genetically modified mesenchymal stem cells with overexpression of HEXA and HEXB genes for the therapy of Tay-Sachs disease//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2021. - Vol.51, Is.. - P.50-51.
- Shaimardanova A., Chulpanova D., Solovyeva V., Development of an AAV9-based gene drug and the method of treatment for metachromatic leukodystrophy//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2021. - Vol.51, Is.. - P.51-52.
-
Chulpanova D.S, Gilazieva Z.E, Akhmetzyanova E.R, Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-b1 can kill carcinoma cancer cells//Tissue and Cell. - 2021. - Vol.73, Is.. - Art. №101664.
-
Kitaeva K.V, Rizvanov A.A, Solovyeva V.V., Modern methods of preclinical anticancer drug screening using test systems based on cell cultures //Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki. - 2021. - Vol.163, Is.2. - P.155-176.
-
Filin I.Y, Kitaeva K.V, Rutland C.S, Recent Advances in Experimental Dendritic Cell Vaccines for Cancer//Frontiers in Oncology. - 2021. - Vol.11, Is.. - Art. №730824.
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, Serum cytokine profile, beta-hexosaminidase a enzymatic activity and gm2 ganglioside levels in the plasma of a tay-sachs disease patient after cord blood cell transplantation and curcumin administration: A case report//Life. - 2021. - Vol.11, Is.10. - Art. №1007.
-
Tazetdinova L.G, Mullagulova A.I, Solovyeva V.V, Contribution of multipotent mesenchymal stromal cells in the tumor microenvironment and carcinogenesis//Genes and Cells. - 2021. - Vol.16, Is.2. - P.31-38.
- Filin IY, Kitaeva KV, Chulpanova DS, Analysis if CD markers of immune cells after interaction with melanoma cells membrane vesicles//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A99-A99.
- Chulpanova DS, Pukhalskaia TV, Rizvanov AA, Artificial membrane vesicles isolated from mesenchymal stem cells with IL2 overexpression activate CD8(+) T-killers to kill triple negative breast cancer cells//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A140-A140.
- Shaimardanova AA, Chulpanova DS, Solovyeva VV, Assessment of functional activity of AAV9 encoding ARSA in the minipig model in vivo//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A63-A63.
- Chulpanova DS, Gilazieva ZE, Kletukhina SK, Cytochalasin B-Induced Membrane Vesicles from Human Mesenchymal Stem Cells Overexpressing IL2 Are Able to Stimulate CD8(+) T-Killers to Kill Human Triple Negative Breast Cancer Cells//BIOLOGY-BASEL. - 2021. - Vol.10, Is.2. - Art. №141.
- Chulpanova DS, Gilazieva ZE, Akhmetzyanova ER, Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-beta 1 can kill carcinoma cancer cells//TISSUE & CELL. - 2021. - Vol.73, Is.. - Art. №101664.
- Shaimardanova AA, Chulpanova DS, Solovyeva VV, Development of cell-mediated gene therapy for Tay-Sachs disease//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A147-A147.
- Issa SS, Shaimardanova AA, Chulpanova DS, Development of cell-mediated gene therapy method for metachromatic leukodystrophy using modified mesenchymal stem cells//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A142-A142.
- Gilazieva ZE, Ponomarev AS, Solovyeva VV, Evaluation of induced membrane vesicles effect on tumor spheroids//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A146-A146.
- Kitaeva KV, Rizvanov AA, Solovyeva VV, Modern Methods of Preclinical Anticancer Drug Screening Using Test Systems Based on Cell Cultures//UCHENYE ZAPISKI KAZANSKOGO UNIVERSITETA-SERIYA ESTESTVENNYE NAUKI. - 2021. - Vol.163, Is.2. - P.155-176.
- Shaimardanova AA, Chulpanova DS, Solovyeva VV, Serum Cytokine Profile, Beta-Hexosaminidase A Enzymatic Activity and GM(2) Ganglioside Levels in the Plasma of a Tay-Sachs Disease Patient after Cord Blood Cell Transplantation and Curcumin Administration: A Case Report//LIFE-BASEL. - 2021. - Vol.11, Is.10. - Art. №1007.
- Pukhalskaia TV, Chulpanova DS, Rizvanov AA, The influence of cytochalasin B-induced membrane vesicles derived from mesenchymal stem cells overexpressing TRAIL on the expression of apoptotic genes in triple-negative MDA-MB-231 breast cancer cells//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A143-A143.
- Kitaeva KV, Filin IY, Chulpanova DS, The proliferative activity and cytokine secretion changes in mesenchymal stem cell and neuroblastoma cells during co-culture under hypoxic conditions//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A150-A151.
-
Lo Sasso G, Khachatryan L, Kondylis A, Inflammatory Bowel Disease-Associated Changes in the Gut: Focus on Kazan Patients//Inflammatory bowel diseases. - 2021. - Vol.27, Is.3. - P.418-433.
2020
-
Shaimardanova A, Solovyeva V, Chulpanova D, Extracellular vesicles in the diagnosis and treatment of central nervous system diseases//Neural Regeneration Research. - 2020. - Vol.15, Is.4. - P.586-596.
- I.I. Abdrakhmanova, D.S. Chulpanova, V.M. Chernov, V.V. Solovyeva, E.Y. Zakirova, A.A. Rizvanov. Analysis of antitumor activity of canine mesenchymal stem cells expressing tumor suppressors and immunomodulator genes in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.84-84
-
Kitaeva K.V, Rutland C.S, Rizvanov A.A, Cell Culture Based in vitro Test Systems for Anticancer Drug Screening//Frontiers in Bioengineering and Biotechnology. - 2020. - Vol.8, Is.. - Art. № 322.
-
Chulpanova D.S, Kitaeva K.V, Green A.R, Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy//Frontiers in Cell and Developmental Biology. - 2020. - Vol.8, Is.. - Art. № 402.
-
Chulpanova D.S, Kitaeva K.V, Rutland C.S, Mouse tumor models for advanced cancer immunotherapy//International Journal of Molecular Sciences. - 2020. - Vol.21, Is.11. - P.1-15.
-
Chulpanova D.S, Solovyeva V.V, Isaeva G.S, Recombinant histone H1.3 inhibits orthohantavirus infection in vitro//BioNanoScience. - 2020. - Vol., Is.. - .
-
Solovyeva V.V, Shaimardanova A.A, Chulpanova D.S, Tay-Sachs disease: Diagnostic, modeling and treatment approaches//Genes and Cells. - 2020. - Vol.15, Is.1. - P.17-22.
-
Chulpanova D.S, Solovyeva V.V, James V, Human mesenchymal stem cells overexpressing interleukin 2 can suppress proliferation of neuroblastoma cells in co-culture and activate mononuclear cells in vitro//Bioengineering. - 2020. - Vol.7, Is.2. - P.1-27.
- Filin I., Kitaeva K., Chulpanova D., Analysis of the interaction of colon carcinoma cell-derived extracellular vesicles and human T-cells in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.88-89.
- Kitaeva K., Chulpanova D., Filin I., Apoptotic gene mRNA expression in mesenchymal stromal cells and neuroblastoma cells after co-culturing and cisplatin treatment//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.83-83.
- Tazetdinova L., Gilazieva Z., Arkhipova S., Lentiviral-based reporter constructs for bioluminescent in vivo imaging//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.91-91.
-
Gilazieva Z, Ponomarev A, Rutland C, Promising applications of tumor spheroids and organoids for personalized medicine//Cancers. - 2020. - Vol.12, Is.10. - P.1-19.
- Gilazieva Z., Ponomarev A., Zhuravleva M., The effect of mesenchymal stem cell derived extracellular vesicles on tumor spheroids in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.82-82.
- Shaimardanova A., Chulpanova D., Solovyeva V., Production and functional analysis of a recombinant genetic construct that simultaneously encodes beta-hexosaminidase A alpha-and beta-subunit genes//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.87-88.
- Shaimardanova A., Chulpanova D., Solovyeva V., The effect of cord blood cell transplantation and curcumin administration on plasma HexA activity and serum cytokine profile in Tay-Sachs disease patient//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.40-41.
- Chulpanova D., Solovyeva V., Rizvanov A., The effect of mesenchymal stem cells with overexpression of cytokines on the viability of human melanoma//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.81-81.
- Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine / Gilazieva Z, Ponomarev A, Rutland C, Rizvanov A, Solovyeva V./ / Cancers (Basel). 2020 Sep 23;12(10):E2727. doi: 10.3390/cancers12102727. PMID: 32977530.
- Chulpanova D., Shaimardanova A., Tazetdinova L., Immunomodulating properties of mesenchymal stem cells with simultaneous overexpression of TRAIL, PTEN and IFN beta 1//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.88-88.
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches//Frontiers in Medicine. - 2020. - Vol.7, Is.. - Art. № 576221.
- Abdrakhmanova I., Chulpanova D., Shaimardanova A., Analysis of antitumor activity of canine mesenchymal stem cells expressing tumor suppressors and immunomodulator genes in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.84-84.
- Chulpanova D., Rizvanov A., Solovyeva V., Analysis of the antitumor activity of extracellular vesicles isolated from mesenchymal stem cells with overexpression of cytokines and tumor suppressors//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.81-82.
-
Filin I.Y, Solovyeva V.V, Kitaeva K.V, Current trends in cancer immunotherapy//Biomedicines. - 2020. - Vol.8, Is.12. - P.1-36.
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, New therapeutic strategies for the treatment of metachromatic leukodystrophy//Genes and Cells. - 2020. - Vol.15, Is.2. - P.41-50.
- Ataei A., Solovyeva V. V., Rizvanov A. A., Tumor Microenvironment: A Key Contributor to Cancer Progression, Invasion, and Drug Resistance//UCHENYE ZAPISKI KAZANSKOGO UNIVERSITETA-SERIYA ESTESTVENNYE NAUKI. - 2020. - Vol.162, Is.4. - P.507-528.
-
Chulpanova D.S, Shaimardanova A.A, Solovyeva V.V, iPSCs for modeling lysosomal storage diseases//Recent Advances in iPSC Disease Modeling. - 2020. - Vol., Is.. - P.1-28.
-
Chulpanova, D. S., Solovyeva, V. V., James, V., Arkhipova, S. S., Gomzikova, M. O., Garanina, E. E., Akhmetzyanova, E.R., Tazetdinova, L.G., Khaiboullina, S.F. & Rizvanov, A. A. (2020). Human mesenchymal stem cells overexpressing interleukin 2 can suppress proliferation of neuroblastoma cells in co-culture and activate mononuclear cells in vitro. Bioengineering, 7(2), 59.
bioengineering_07_00059.pdf -
Генетическая кассета, содержащая кодон - оптимизированные нуклеотидные последовательности генов HEXA и HEXВ, и фармацевтическая композиция для лечения болезни Тея - Сакса: Пат. 2723187 Российская Федерация, МПК C 12 N 9/24, C 12 N 15/63, C 12 N 15/85, A 61 K 38/47, A 61 K 48/00, A 61 P 25/28 / А. А. Шаймарданова, Д. С. Чулпанова, В. В. Соловьева, А. А. Ризванов; заявитель и патентообладатель Казан. федер. ун-т. - № 2019131306 ; заявл. 04.10.2019 ; опубл. 09.06.2020, Бюл. № 16.
F_Patent_geneticheskaya_kasseta_BTS.pdf
2019
- Garanina Ekaterina, Chulpanova Daria, Solovyeva Valeriya, Multiplex analysis of conditioned medium of mesenchymal stem cells with IL2 overexpression//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2019. - Vol.49, Is.. - P.162-163.
- Филин И.Ю., Китаева К.В., Чулпанова Д.С., Ризванов А.А., Соловьева В.В. Анализ взаимодействия внеклеточных везикул клеток карциномы толстой кишки с Т-лимфоцитами человека in vitro / И.Ю. Филин, К.В. Китаева, Д.С. Чулпанова, А.А. Ризванов, В.В. Соловьева // Материалы IV Национального конгресса по регенеративной медицине. Гены и клетки. - Москва. - 2019. - Том XIV, Приложение. - С. 243.
- Rizvanov Albert, Chulpanova Daria, Solovyeva Valeriya, Preparation and analysis of artificial extracellular vesicles from mesenchymal stem cells overexpressing TRAIL, PTEN or IFNA17//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2019. - Vol.49, Is.. - P.166-166.
- Rizvanov Albert, Kitaeva Kristina, Chulpanova Daria, The effect of intercellular interaction of MSC and SH-SY5Y in co-culture on result of cisplatin treatment//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2019. - Vol.49, Is.. - P.166-166.
- Kitaeva Kristina V., Prudnikov Tikhon S., Gomzikova Marina O., Analysis of the Interaction and Proliferative Activity of Adenocarcinoma, Peripheral Blood Mononuclear and Mesenchymal Stromal Cells after Co-Cultivation In Vitro//BIONANOSCIENCE. - 2019. - Vol.9, Is.2. - P.502-509.
-
Solovyeva V.V, Chulpanova D.S, Tazetdinova L.G, In Vitro Angiogenic Properties of Plasmid DNA Encoding SDF-1? and VEGF165 Genes//Applied Biochemistry and Biotechnology. - 2019. - Vol., Is.. - .
-
Shaimardanova A.A, Kitaeva K.V, Abdrakhmanova I.I, Production and application of multicistronic constructs for various human disease therapies//Pharmaceutics. - 2019. - Vol.11, Is.11. - Art. № 580.
- Tazetdinova L. G., Chulpanova D. S., Fazleeva I. I., Production of mouse mesenchymal stem cell lines with Luciferase and Katushka2s reporter gene expression for bioluminescence imaging//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A64-A64.
- Kitaeva K. V., Chulpanova D. S., Prudnikov T. S., The effect of co-culturing of MSC and SH-SY5Y and cisplatin treatment on proliferative activity and caveolin-1 mRNA expression//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A62-A62.
- Tazetdinova L., Arkhipova S., Baranova V., An immunocompetent mouse model of human neuroblastoma//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A58-A58.
- Kitaeva K. V., Chulpanova D. S., Prudnikov T. S., Analysis of Rac1, Bcl2, Cav1 alpha, and Cav1 beta gene expression of neuroblastoma cells, mesenchymal stem cells and human peripheral blood mononuclear cells after co-cultivation//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A66-A66.
- Chulpanova D. S., Kletukhina S. K., Rizvanov A. A., Antitumor properties of artificial microvesicles from mesenchymal stem cells overexpressing TNF-related apoptosis inducing ligand//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A63-A63.
- Iakovlev I. A., Deev R. V., Buev D. O., Assessment of exon-skipping feasibility for treatment of dysferlinopathy//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A166-A166.
- Starostina I. G., Shaimardanova A. A., Agliullina D. R., Gene modification of HEK293A cells using CRISPR-Cas9 SAM technology for the transcriptional activation of dysferlin gene//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A190-A190.
- Shaimardanova A. A., Chulpanova D. S., Solovyeva V. V., Generation and functional analysis of plasmid DNA encoding beta-hexosaminidase gene for Tay-Sachs disease therapy//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A155-A156.
-
Аглиуллина Д.Р. Коррекция мутаций в экзонах 26 и 3 гена дисферлина путем проведения искусственного транс-сплайсинга / Д.Р. Аглиуллина, И.Г. Старостина, И.А. Яковлев, Р.В. Деев, А.А. Исаев, В.В. Соловьева, А.А. Ризванов // Сборник тезисов 23-ой Международной Пущинской школы-конференции молодых ученых
«Биология - наука XXI века». - 2019ю - С.328.
F_sbornik_2019.pdf -
Starostina I.G. Editing on RNA and DNA levels of dysferlin gene exon 26 for dysferlinopathy treatment / I.G. Starostina, D.R. Agliullina, A.A. Shaimardanova, I.A. Yakovlev, V.V. Solovyeva, R.V. Deev, A.A. Isaev, A.A. Rizvanov // 3rd Sechenov international biomedical summit (SIBS 2019), abstract book. - 2019. - P.31.
F_2019_theses_SIBS_ENG.pdf -
Старостина И.Г. Активация транскрипции мутантного гена дисферлина
в фибробластах кожи человека с использованием технологии
CRISPR-Cas9 SAM как тест-система для подбора лекарственных
препаратов при дисферлинопатиях / И.Г. Старостина, А.А. Шаймарданова, В.В. Соловьева, Д.Р. Аглиуллина, И.А. Яковлев, Р.В. Деев, А.А. Исаев, А.А. Ризванов А.А // МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ, ПОСВЯЩЁННАЯ ПАМЯТИ АКАДЕМИКА ЕВГЕНИЯ ЕВГЕНЬЕВИЧА НИКОЛЬСКОГО АКТУАЛЬНЫЕ ПРОБЛЕМЫ
НЕЙРОБИОЛОГИИ, тезисы докладов. - 2019. - С.133-134.
F_Sbornik.pdf - Старостина И.Г. MyoD-индуцированная трансдифференцировка дермальных фибробластов с мутацией в гене DYSF, рассматриваемая как тест-система для скрининга препаратов дисферлинопатии / И. Г. Старостина, Д.С. Чулпанова, А.А. Шаймарданова, В.В. Соловьева, И.А. Яковлев, Р.В. Деев, А.А. Исаев, А.А. Ризванов // Научно-практический журнал «Гены и Клетки«, материалы IV Национального конгресса по регенеративной медицине. - 2019. - Том XIV, Приложение, 2019. - С.220-221.
- Старостина И.Г. Модификация клеток HEK293A с использованием технологии CRISPR-Cas9 SAM для транскрипционной активации гена дисферлина / И. Г. Старостина, А.А. Шаймарданова, Д.Р. Аглиуллина, В.В. Соловьева, И.А. Яковлев, А.А. Исаев, Р.В. Деев, А.А. Ризванов // Научно-практический журнал «Гены и Клетки«, материалы IV Национального конгресса по регенеративной медицине. - 2019. - Том XIV, Приложение, 2019. - С.221.
- Яковлев И.А. Применение CRISPR-опосредованной транскрипционной активации с целью создания клеточных тест-систем для разработки и проверки методов генной терапии наследственных заболеваний мышечной ткани / И.А. Яковлев, И. Г. Старостина, Д.С. Чулпанова, А.А. Шаймарданова, В.В. Соловьева, А.А. Ризванов, Р.В. Деев, А.А. Исаев // Научно-практический журнал «Гены и Клетки«, материалы IV Национального конгресса по регенеративной медицине. - 2019. - Том XIV, Приложение, 2019. - С.270.
- Тазетдинова Л.Г., Чулпанова Д.С., Фазлеева И.И., Филин И.Ю., Соловьева В.В., Ризванов А.А. Анализ противоопухолевой активности мезенхимных стволовых клеток, загруженных препаратом цисплатин, в культуре клеток нейробластомы in vitro / Л.Г. Тазетдинова, Д.С. Чулпанова, И.И. Фазлеева, И.Ю. Филин, В.В. Соловьева, А.А. Ризванов // Актуальные проблемы нейробиологии – Казань – 2019 – С. 79 – 80
- Tazetdinova L., Arkhipova S., Baranova V., Abdrakhmanova I., Filin I., Mullagulova A., Chulpanova D., Solovyeva V., Rizvanov A. An immunocompetent mouse model of human neuroblastoma / L. Tazetdinova, S. Arkhipova, V. Baranova, I. Abdrakhmanova, I. Filin, A. Mullagulova, D. Chulpanova, V. Solovyeva, A. Rizvanov // HUMAN GENE THERAPY. - 2019. - Vol. 30, Is. 11. - P. A58-A58.
- Tazetdinova L.G., Chulpanova D.S., Fazleeva I.I., Filin I.Y., Mullagulova A.I., Solovyeva V.V., Rizvanov A.A. Production of mouse mesenchymal stem cell lines with Luciferase and Katushka2s reporter gene expression for bioluminescence imaging / L.G. Tazetdinova, D.S. Chulpanova, I.I. Fazleeva, I.Y. Filin, A.I. Mullagulova, V.V. Solovyeva, A.A. Rizvanov // HUMAN GENE THERAPY. - 2019. - Vol. 30, Is. 11. - P. A64-A64.
- Tezcan Gulcin, Gillazieva Zarema, Arkhipova Svetlana, Paracrine effect of bone marrow and adipose tissue mesenchymal stem cell derived extracellular vesicles on Glioblastoma//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2019. - Vol.49, Is.. - P.90-91.
2018
-
Chulpanova D.S, Kitaeva K.V, Tazetdinova L.G, Application of Mesenchymal stem cells for therapeutic agent delivery in anti-tumor treatment//Frontiers in Pharmacology. - 2018. - Vol.9, Is.MAR. - Art. № 259.
- Chulpanova D. S., Arkhipova S. S., Solovyeva V. V., The effect of interleukin 2 overexpression on the ultrastructure of human mesenchymal stem cells.//MOLECULAR BIOLOGY OF THE CELL. - 2018. - Vol.29, Is.26. - .
- Chulpanova D., Solovyeva V., Tazetdinova L., Generation and analysis of mesenchymal stem cell line stably expressing IL2//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.87-87.
- Chulpanova Daria S., Kitaeva Kristina V., James Victoria, Therapeutic Prospects of extracellular vesicles in Cancer Treatment//FRONTIERS IN IMMUNOLOGY. - 2018. - Vol.9, Is.. - Art. №1534.
- Tazetdinova L., Gilazieva Z., Arkhipova S., Viability and ultrastructure of human mesenchymal stem cells primed with cisplatin//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.87-87.
- Kitaeva K., Prudnikov T., Rizvanov A., The trophic role of mesenchymal stem cells in co-culture with neuroblastoma cells//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.88-88.
-
Front. Physiol. ? 2018.
- Chulpanova D.S. Production and analysis of stable mesenchymal stem cell culture with IL-2 overexpression / D.S. Chulpanova, V.V. Solovyeva, L.G. Tazetdinova, S.K. Kletukhina, A.A. Rizvanov // Abstract book «Kazan precision medicine workshop», Kazan. - September 10-12, 2018. – P.13
-
Solovyeva V.V, Shaimardanova A.A, Chulpanova D.S, New approaches to Tay-Sachs disease therapy//Frontiers in Physiology. - 2018. - Vol.9, Is.NOV. - Art. № 1663.
-
Chulpanova D.S, Solovyeva V.V, Kitaeva K.V, Recombinant viruses for cancer therapy//Biomedicines. - 2018. - Vol.6, Is.4. - Art. № 94.
- Starostina I. G., Solovyeva V. V., Shaimardanova A. A., Analysis of ectopic dysferlin expression effect on the proliferative activity of HEK293A cells after electroporation//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A99-A99.
- Solovyeva V. V., Kitaeva K. V., Chulpanova D. S., Analysis of the interaction of mesenchymal stem cells with artificial human neuroblastoma cell-derived microvesicles using imaging flow cytometry//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A70-A70.
- Starostina I. G., Shaimardanova A. A., Solovyeva V. V., Biosynthesis of DYSF protein in Bla/J dysferlin-deficient mice after administration of recombinant adenovirus encoding dysferlin cDNA//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A138-A138.
- Tazetdinova L. G., Chulpanova D. S., Gilazieva Z. E., Effect of genetic modification with reporter genes on mesenchymal stem cell differential ability into osteogenic, adipogenic and chondrogenic lineages//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A78-A79.
- Chulpanova D. S., Solovyeva V. V., Zakirova E. Yu, Generation of genetically engineered canine mesenchymal stem cells co-expressing immunomodulating cytokines and tumour suppressors//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A52-A53.
- Chulpanova D. S., Solovyeva V. V., Tazetdinova L. G., IL-2 genetically modified mesenchymal stem cells demonstrate increased VEGF, MMP2 and TGF-beta 1 genes expression//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A55-A55.
- Chulpanova D. S., Shaimardanova A. A., Solovyeva V. V., MyoD-directed reprogramming of fibroblasts with DYSF gene mutation for human dysferlinopathy modeling//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A98-A98.
- Kitaeva K. V., Prudnikov T. S., Chulpanova D. S., Rac1 and Bcl-2 expression changes in co-culture of mesenchymal stem cells and neuroblastoma cells after incubation with cisplatin//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A54-A55.
- Prudnikov T. S., Kitaeva K. V., Gomzikova M. O., Self-organization and cell proliferation of adipose derived stem cells, HeLa and mononuclear cells after co-culture//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A53-A53.
- Shaimardanova A. A., Starostina I. G., Solovyeva V. V., Transcriptional activation of mutant dysferlin gene expression in human skin fibroblasts using CRISPR/Cas9 SAM technology//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A142-A142.
- Chulpanova Daria, Soloveva Valeriya, Tazetdinova Leisan G., Analysis of the Effect of Mesenchymal Stem Cells Culture with Interleukin 2 Overexpression on Human Mononuclear Cells Activation in Vitro//BLOOD. - 2018. - Vol.132, Is.. - .
- Shaimardanova A.A. Transcriptional activation of mutant dysferlin gene expression in human skin fibroblasts using CRISPR/Cas9 SAM technology / A.A. Shaimardanova, I. G. Starostina, V. V. Solovyeva, D. R. Agliullina, I. A. Yakovlev, A. A. Isaev, R. V. Deev , A .A. Rizvanov // HUMAN GENE THERAPY ? 27: A2?A169. ? P. A142 - 2018.
- Starostina I. G. Analysis of ectopic dysferlin expression effect on the proliferative activity of HEK293A cells after electroporation / I. G. Starostina, V. V. Solovyeva, A. A. Shaimardanova, D. R. Agliullina, A. A. Isaev, R. V. Deev, A. A. Rizvanov // HUMAN GENE THERAPY ? 27: A2?A169. ? P. A99 - 2018.
- Chulpanova D.S. MyoD-directed reprogramming of fibroblasts with DYSF gene mutation for human dysferlinopathy modeling / D.S. Chulpanova, A.A. Shaimardanova, V. V. Solovyeva, I. G. Starostina, I. A. Yakovlev, R. V. Deev, A. A. Isaev, A .A. Rizvanov // HUMAN GENE THERAPY ? 27: A2?A169. ? P. A98 - 2018.
- Kitaeva K. K., Prudnikov T. S., Chulpanova D. S., Cav1a and Cav1b expression changes in co-culture of mesenchymal stem cells and neuroblastoma cells after incubation with cisplatin.//MOLECULAR BIOLOGY OF THE CELL. - 2018. - Vol.29, Is.26. - .
- Tazetdinova L., Gilazieva Z., Arkhipova S., Effect of paclitaxel on ultrastructure of adipose-derived mesenchymal stem cells//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.104-105.
2017
-
Kolobynina K, Solovyeva V, Gomzikova M, Generation of Human Adipose-Derived Stem Cell Lines with Expression of TESC Gene//BioNanoScience. - 2017. - Vol.7, Is.1. - P.92-96.
- Yakovlev I.A. DNA and RNA editing of DYSF gene exon 26 for dysferlinopathy treatment / I.A. Yakovlev, I.G. Starostina, A.A. Shaimardanova, V.V. Solovyeva, A.A. Rizvanov, R.V. Deev, A.A.Isaev // HUMAN GENE THERAPY ? 28. - P.A65 - 2017.
- Tazetdinova L., Solovyeva V., Alekseeva E., Analysis of biological properties and anti-cancer activity in vitro of mesenchymal stem cells primed with cisplatin//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2017. - Vol.47, Is.. - P.139-140.
- Kitaeva K., Prudnikov T., Tazetdinova L., Self-organization of bone marrow derived mesenchymal stromal cells and neuroblastoma cells in different models of extracellular matrix in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2017. - Vol.47, Is.. - P.157-157.
-
Kitaeva, K., Prudnikov, T., Gomzikova, M., Tazetdinova, L., Rizvanov, A., & Soloveva, V. (2017). Analysis of Interactions between CD14+ Monocytes, Mesenchymal Stem Cells and HeLa Cells in Double Co-Cultures In Vitro. Blood, 130(Suppl 1), 4809. Accessed December 12, 2017. Retrieved from http://www.bloodjournal.org/content/130/Suppl_1/4809.
-
Kitaeva K.V. Multicellular spheroid model on extracellular matrix analogue Matrigel / K.V. Kitaeva, T.S. Prudnikov, L.G. Tazetdinova, M.O. Gomzikova, A.A. Rizvanov, V.V. Solovyeva // Новые концепции механизмов воспаления, аутоиммунитета и развития опухоли: материалы VI международной науч.-практ. конф. – Казань. – 2017. – С.36.
-
Kitaeva K.V. Tumor stroma formation on model of extracellular matrix matrigel in vitro /K.V. Kitaeva, T.S. Prudnikov, L.G. Tazetdinova, M.O. Gomzikova, A.A. Rizvanov, V.V. Solovyeva // International Scientific Conference #SCIENCE4HEALTH2017: materials of the conference. – Moscow. – 2017. – P.26.
F__SCIENCE4HEALTH2017___AbstractBook.pdf - Чернова О.Н. Влияние рекомбинантного аденовируса Ad5-Dysf на скелетную мышечную ткань у дисферлин-дефицитных мышей BlaJ / О.Н. Чернова, М.О. Мавликеев, И.А. Яковлев, А.А. Титова, В.В. Соловьева, И.Г. Старостина, А.К. Зейналова, М.С. Калигин, А.А. Ризванов, А.П. Киясов, Р.В. Деев // Актуальные вопросы фундаментальной, экспериментальной и клинической морфологии: материалы Всероссийской конференции молодых специалистов; под ред. Р.В. Деева; ФГБОУ ВО РязГМУ Минздрава России. – Рязань: ООП УИТ-ТиОП, 2017. – С.98.
-
Оценка регенерации скелетной мышечной ткани у мышей линии Bla/J после трансдукции рекомбинантным аденовирусом Ad5-DYSF / О.Н. Чернова, М.О. Мавликеев, И.А. Яковлев, В.В. Соловьева, И.Г. Старостина, А.А. Титова, А.К. Зейналова, М.С. Калигин, А.А. Ризванов, А.П. Киясов, Р.В. Деев // Гены и Клетки.- 2017.- 12(3). - С. 261.
GiK_tezis.pdf -
Китаева К.В. Исследование взаимодействий CD14+ моноцитов со стромальными
и опухолевыми клетками человека при совместном культивировании in vitro / К.В. Китаева, Т.С. Прудников, Л.Г. Тазетдинова, М.О. Гомзикова, В.В. Соловьева, А.А. Ризванов // Материалы III Национального конгресса по регенеративной медицине. Гены и Клетки. - Москва. - 2017. - С.118
F_GK_3_2017_2.pdf - Kitaeva K. V., Prudnikov T. S., Gomzikova M. O., Analysis of self-organisation of mesenchymal stem cells and neuroblastoma cells on Matrigel extracellular matrix//HUMAN GENE THERAPY. - 2017. - Vol.28, Is.12. - P.A48-A48.
- Yakovlev I. A., Starostina I. G., Shaimardanova A. A., DNA and RNA editing of DYSF gene exon 26 for dysferlinopathy treatment//HUMAN GENE THERAPY. - 2017. - Vol.28, Is.12. - P.A65-A65.
- Chernova O. N., Titova A. A., Mavlikeev M. O., Effects of Ad5-DYSF transduction on skeletal muscles of dysferlin-deficient mice//HUMAN GENE THERAPY. - 2017. - Vol.28, Is.12. - P.A43-A43.
- Starostina I. G., Solovyeva V. V., Shaimardanova A. A., Generation and functional analysis in vitro of recombinant pCMV-DYSF plasmid encoding human DYSF gene//HUMAN GENE THERAPY. - 2017. - Vol.28, Is.12. - P.A125-A125.
- Chulpanova D. S., Kolobynina K. G., Solovyeva V. V., Generation of genetically engineered human mesenchymal stem cells expressing immunomodulating cytokines and tumour suppressor//HUMAN GENE THERAPY. - 2017. - Vol.28, Is.12. - P.A39-A39.
- Solovyeva V. V., Deev R. V., Isaev A. A., In vitro angiogenic properties of plasmid encoding SDF-1 alpha and VEGF165 genes//HUMAN GENE THERAPY. - 2017. - Vol.28, Is.12. - P.A123-A124.
- Kolobynina K. G., Solovyeva V. V., Ataei A., Tescalcin overexpression influences mesenchymal stem cell differentiation//HUMAN GENE THERAPY. - 2017. - Vol.28, Is.12. - P.A101-A101.
- Tazetdinova L. G., Alekseeva E. A., Gilazieva Z. E., The effect of cisplatin and paclitaxel on ultrastructure of adipose-derived mesenchymal stem cells//HUMAN GENE THERAPY. - 2017. - Vol.28, Is.12. - P.A102-A102.
- Chulpanova D.S. Production of recombinant lentiviruses encoding anti- tumour human cytokines / D.S. Chulpanova, K.G. Kolobynina, V.V. Solovyeva, A.A. Rizvanov // Новые концепции механизмов воспаления, аутоиммунитета и развития опухоли: материалы VI международной науч.-практ. конф. – Казань. – 2017. – С.93.
- Chulpanova D.S. Generation of genetically engineered human mesenchymal stem cells expressing immunomodulating cytokines and tumor suppressors / D.S. Chulpanova, K.G. Kolobynina, V.V. Solovyeva, L.G. Tazetdinova, S.S. Arkhipova, A.A. Rizvanov // Human Gene Therapy. – 2017 – V.28. – P.A39.
- Starostina I.G. Generation and Analysis of Genetically Modified CD14+ Monocytes with Dysferlin Overexpression / Irina Starostina, Valeriya Soloveva, Alisa Shaimardanova, Roman Deev, Arthur Isaev and Albert Rizvanov // Blood, 130(Suppl 1). - 5565. - 2017
- Starostina I.G. Generation and functional analysis in vitro of recombinant pCMV-DYSF plasmid encoding human DYSF gene / I.G. Starostina, V.V. Solovyeva, A.A. Shaimardanova, R.V. Deev, A.A. Isaev, A.A. Rizvanov // HUMAN GENE THERAPY ? 28. - P.A12 - 2017.
-
K.V. Kitaeva, T.S. Prudnikov, L.G. Tazetdinova, M.O. Gomzikova, A.A. Rizvanov, V.V. Solovyeva Self-organization of bone marrow derived mesenchymal stromal cells and neuroblastoma cells in different models of extracellular matrix in vitro / (2017), Poster Abstract. Eur J Clin Invest, 47: 157. doi:10.1111/eci.12749
F_2017_European_Journal_of_Clinical_Investigation.pdf
2016
- Starostina I.G. Genetically engineered construction and creation of a recombinant adenovirus as an approach for gene therapy of dysferlinopathies / I.G. Starostina, V.V. Solovyova, A.A. Rizvanov, R.V. Deev // Medicine. – 2016. – V.95(10). – P.20-21.
-
Kolobynina K.G. Emerging roles of the single EF-hand Ca2+ sensor tescalcin in the regulation of gene expression, cell growth and differentiation / K.G. Kolobynina, V.V. Solovyova, K.Levay, A.A. Rizvanov, V.Z. Slepak // Journal of Cell Science. - 2016. - Р. 1-8.
10.1242_jcs.191486.pdf -
Kolobynina K.G, Solovyova V.V, Levay K, Emerging roles of the single EF-hand Ca2+ sensor tescalcin in the regulation of gene expression, cell growth and differentiation//Journal of Cell Science. - 2016. - Vol.129, Is.19. - P.3533-3540.
-
Yakovlev I.A, Deev R.V, Solovyeva V.V, Pre- and posttranscriptional genetic information modification in muscular dystrophy treatment//Genes and Cells. - 2016. - Vol.11, Is.2. - P.42-51.
- Davidovich P., Sayarova R., Valiullina A., Novel isatin-Schiff base copper (II) complexes as potential p53-activating pro-apoptotic agents.//MOLECULAR BIOLOGY OF THE CELL. - 2016. - Vol.27, Is.. - P1116.
-
Gilazieva Z, Tazetdinova L, Arkhipova S, Effect of Cisplatin on Ultrastructure and Viability of Adipose-Derived Mesenchymal Stem Cells//BioNanoScience. - 2016. - Vol.6, Is.4. - P.534-539.
-
Solovyeva Valeriya V., Kiyasov Andrey P., Rizvanov Albert A., Genetically Engineered Dental Stem Cells for Regenerative Medicine // DENTAL STEM CELLS. - 2016. - Vol., Is.. - P.93-107.
- Yakovlev I. A., Deev R. V., Rizvanov A. A., Mutation correction in exons 3 and 26 of DYSF gene by artificial trans-splicing//HUMAN GENE THERAPY. - 2016. - Vol.27, Is.11. - P.A137-A138.
-
Ataei A, Solovyeva V.V, Poorebrahim M, A Genome-Wide Analysis of mRNA Expression in Human Tooth Germ Stem Cells Treated with Pluronic P85//BioNanoScience. - 2016. - Vol.6, Is.4. - P.392-402.
2015
-
Islamov R.R. Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule / R.R. Islamov, A.A. Rizvanov, M.A. Mukhamedyarov, I.I. Salafutdinov, E.E. Garanina, V.Y. Fedotova, V.V. Solovyeva, Y.O. Mukhamedshina, Z.Z. Safiullov, A.A. Izmailov, D.S. Guseva, A.L. Zefirov, A.P. Kiyasov, A. Palotás // Current Gene Therapy. - 2015. - Vol.15, Issue 2. - P.266-276.
-
Соловьева В.В. Сверхэкспрессия тескалцина стволовыми клетками из жировой ткани человека приводит к повышению секреции интерлейкина 6 / В.В. Соловьева, К.Г. Колобынина, М.О. Гомзикова, Л.Г. Тазетдинова, Е.В. Мартынова, С.Ф. Хайбуллина, В.З. Слепак, А.А. Ризванов // Биология-наука ХХI века: 19-я Международная Пущинская школа-конференция молодых ученых. Сборник тезисов. - Пущино. - 2015. - С.370.
-
Islamov R.R. Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule. R.R. Islamov, A.A. Rizvanov, M.A. Mukhamedyarov, I.I. Salafutdinov, E.E. Garanina, V.Y. Fedotova, V.V. Solovyeva, Y.O. Mukhamedshina, Z.Z. Safiullov, A.A. Izmailov, D.S. Guseva, A.L. Zefirov, A.P. Kiyasov, A. Palotás. Current Gene Therapy. – 2015. – Vol.15, Issue 2. – P. 266-276
2015_CCL27_Novel_Cytokine_with_Potential_Role.pdf - Islamov R.R. Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule / R.R. Islamov, A.A. Rizvanov, M.A. Mukhamedyarov, I.I. Salafutdinov,E.E.Garanina, Fedotova VY, Solovyeva VV, Mukhamedshina YO, Safiullov ZZ, Izmailov AA, Guseva DS, Zefirov AL, Kiyasov AP, Palotas A / Current Gene Therapy. - 2015. - 15(3)-266-76.
-
Solovyeva V.V., Rizvanov A.A. Application of anticancer drug based on recombinant histone protein as inhibitor of adenoviral infection in vitro. European journal of clinical investigation. European journal of clinical investigation - Vol.45. - P.52.
Solovyeva_V.pdf -
Kolobynina K.G, Solovyeva V.V, Slepak V.Z, The role of EF-hand Ca2+/Mg2+-binding tescalcin protein in cell proliferation and differentiation//Genes and Cells. - 2015. - Vol.10, Is.1. - P.28-34.
-
Solovyeva, V.V., Kolobynina, K.G., Gomzikova, M.O., Tazetdinova, L.G., Zhuravleva, M.N., Slepak, V.Z., Rizvanov, A.A. Effect of tescalcin overexpression on osteogenic differentiation of human mesenchymal stem cells / Genes and Cells. - 2015. - V.10(4). - p.90-93
-
Solovyeva V.V, Blatt N.L, Guseva D.S, Expression of pluripotency transcription factors in human third molar tooth germ derived multipotent mesenchymal stromal cells transfected by plasmid pBud-Sox2-Oct4//Genes and Cells. - 2015. - Vol.10, Is.2. - P.65-70.
-
Petukhova, E.O., Mukhamedshina, Y.O., Vasilieva, O.Y., Aksenova, L.Y., Solovyeva, V.V., Garanina, E.E., Rizvanov, A.A., Zefirov, A.L., Islamov, R.R., Mukhamedyarov, M.A. Stimulation of neurogenesis at hippocampus in Alzheimer's disease / Genes and Cells. - 2015. - V.10(4). - p.54-59
- Solovyeva V.V. Tescalcin overex-pression by adipose derived stem cells results in increase in IL-6 secretion / V. V. Solovyeva, K.G. Kolobynina, M.O. Gomzikova, L.G. Tazetdinova, E.V. Martynova, S.F. Khaiboullina, V.Z. Slepak, A.A. Rizvanov // Book of abstracts Ensor Workshop Nanocarbon materials, biomaterials and composites. - 2015. - P. 11.
-
Kolobynina K.G, Solovyeva V.V, Slepak V.Z, The role of EF-hand Ca2+/Mg2+-binding tescalcin protein in cell proliferation and differentiation//Genes and Cells. - 2015. - Vol.10, Is.1. - P.28-34.
- Колобынина К.Г. Влияние сверхэкспрессии тескалцина на дифференцировку мезенхимных стволовых клеток человека в остеогенном направлении/ К. Г. Колобынина, В.В. Соловьева, М.О. Гомзикова, Л.Г. Тазетдинова, М.Н. Журавлева, В.З. Слепак, А.А. Ризванов // Сборник тезисов I Международной школы-конференции студентов, аспирантов и молодых ученых «Биомедицина, материалы и технологии XXI века«. Казань. - 2015. - С. 106.
2014
-
Solovyeva V.V. Genetic Modification of Adipose Derived Stem Cells with Recombinant Plasmid DNA pBud-VEGF-FGF2 Results in Increased of IL-8 and MCP-1 Secretion / V.V. Solovyeva, I.I. Salafutdinov, L.G. Tazetdinova, R.F. Masgutov, S.F. Khaiboullina, A.A. Rizvanov // Journal of pure and applied microbiology. – 2014. – Vol.8, Spl.Edn.2. – P.523-528.
-
Zaitsev S.Y. Conjugates of a photoactivated rhodamine with biopolymers for cell staining / S.Y. Zaitsev, M.N. Shaposhnikov, D.O. Solovyeva, V.V. Solovyeva, A.A. Rizvanov // The Scientific World Journal. – 2014. – V.2014. - Article ID 285405. – doi: 10.1155/2014/285405.
-
Solovyeva V.V, Rizvanov A.A., Application of recombinant histone protein H1.3 for inhibition of adenoviral infection//Genes and Cells. - 2014. - Vol.9, Is.3. - P.125-130.
-
Solovyeva, V.V., Salafutdinov, I.I., Tazetdinova, L.G., Khaiboullina, S.F., Masgutov, R.F., Rizvanov, A.A. Genetic modification of adipose derived stem cells with recombinant plasmid DNA pBud-VEGF-FGF2 results in increased of IL-8 and MCP-1 secretion / Journal of Pure and Applied Microbiology. - 2014. - V.8. - p.523 - 528
2014_Genetic_Modification_of_Adipose_Derived_Stem_Cells_with.pdf -
Shaposhnikov M.N, Solovyeva D.O, Zaitsev S.Yu, Intracellular localization analysis of a conjugate of recombinant histone H1.3 with photoactivated fluorescent dye//Genes and Cells. - 2014. - Vol.9, Is.3. - P.289-294.
-
Zaitsev S.Y., Shaposhnikov M.N., Solovyeva D.O., Solovyeva V.V., Rizvanov A.A. Conjugates of a photoactivated rhodamine with biopolymers for cell staining / Scientific World Journal. - 2014. - V.2014. - Article ID 285405
2014_Conjugates_of_a_Photoactivated_Rhodamine_with.pdf
2013
-
Blatt N.L. Application of Cell and Tissue Culture Systems for Anticancer Drug Screening / N.L. Blatt, R.N. Mingaleeva, V.V. Solovieva, S.F. Khaiboullina, V.C. Lombardi, A.A. Rizvanov // World Applied Sciences Journal. – 2013. – Vol.23, No.3. – P.315-325.
-
Solovyeva V.V. Human Adipose Derived Stem Cells Do Not Alter Cytokine Secretion in Response To The Genetic Modification With pEGFP-N2 Plasmid DNA / V.V. Solovyeva, I.I. Salafutdinov, E.V. Martynova, S.F. Khaiboullina, A.A. Rizvanov // World Applied Sciences Journal. – 2013. – Vol.26, No.7. – P.968-972.
-
Mukhamedyarov M.A. Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype / M.A. Mukhamedyarov, A.A. Rizvanov, Z.Z. Safiullov, A.A. Izmailov, G.A. Sharifullina, V.V. Solovieva, V.Yu. Fedotova, I.I. Salafutdinov, E.E. Cherenkova, F.V. Bashirov, M.S. Kaligin, S.R. Abdulkhakov, M.M. Shmarov, D.Yu. Logunov, B.S. Naroditsky, A.P. Kiyasov, A.L. Zefirov, R.R. Islamov // Bulletin of Experimental Biology and Medicine. - Vol.154, №4. - P.558-561.
-
Starostina I.G, Solovyeva V.V, Yuryeva K.S, Modeling and gene therapy of dysferlinopathy//Cellular Transplantation and Tissue Engineering. - 2013. - Vol.8, Is.3. - P.61-70.
-
Mingaleeva R.N, Solovieva V.V, Blatt N.L, Application of cell and tissue cultures for potential anti-cancer/oncology drugs screening in vitro//Cellular Transplantation and Tissue Engineering. - 2013. - Vol.8, Is.2. - P.20-28.
-
Solovyeva V.V, Salafutdinov I.I, Martynova E.V, Human adipose derived stem cells do not alter cytokine secretion in response to the genetic modification with pEGFP-N2 plasmid DNA//World Applied Sciences Journal. - 2013. - Vol.26, Is.7. - P.968-972.
-
Mukhamedyarov M.A, Rizvanov A.A, Safiullov Z.Z, Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype//Bulletin of Experimental Biology and Medicine. - 2013. - Vol.154, Is.4. - P.558-561.
2012
-
Мухамедшина Я.О. Анализ экспрессии рекомбинантного гена vegf генетически модифицированными мононуклеарными клетками пуповинной крови в эксперименте in vivo / Я.О. Мухамедшина, В.В. Соловьева, И.И. Салафутдинов, Е.Е. Черенкова, В.Ю. Федотова, З.З. Сафиуллов, А.А. Измайлов, Г.А. Шарифуллина, С.Р. Абдулхаков, М.С. Калигин, Ф.В. Баширов, М.А. Мухамедьяров, М.М. Шмаров, Б.С. Народицкий, А.П. Киясов, А.А. Ризванов, Р.Р. Исламов // Клеточная трансплантология и тканевая инженерия. - 2012. - Т.7, №3. - С.130-134.
-
Мухамедьяров М.А. Анализ эффективности генно-клеточной терапии у трансгенных мышей с фенотипом бокового амиотрофического склероза / М.А. Мухамедьяров, А.А. Ризванов, З.З. Сафиуллов, А.А. Измайлов, Г.А. Шарифуллина, В.В. Соловьёва, В.Ю. Федотова, И.И. Салафутдинов, Е.Е. Черенкова, Ф.В. Баширов, М.С. Калигин, С.Р. Абдулхаков, М.М. Шмаров, Д.Ю. Логунов, Б.С. Народицкий, А.П. Киясов, А.Л. Зефиров, Р.Р. Исламов // Клеточные технологии в биологии и медицине. - 2012. - №4. - С.215-219.
-
Solovyeva V.V, Isaev A.A, Genkin D.D, Influence of recombinant histone H1.3 on the efficiency of lentiviral transduction of human cells in vitro//Cellular Transplantation and Tissue Engineering. - 2012. - Vol.7, Is.3. - P.151-154.
-
Mukhamedshina Y.O, Solovieva V.V, Salafutdinov I.I, Analysis of recombinant VEGF gene expression by genetically modified umbilical cord blood mononuclear cells in experiment in vivo//Cellular Transplantation and Tissue Engineering. - 2012. - Vol.7, Is.3. - P.130-134.
-
Starostina I.G, Solovyeva V.V, Shevchenko K.G, Formation of the recombinant adenovirus encoding codon-optimized dysferlin gene and analysis of the recombinant protein expression in cell culture in vitro//Cellular Transplantation and Tissue Engineering. - 2012. - Vol.7, Is.3. - P.25-28.
-
Solovyeva V.V, Blatt N.L, Shafigullina A.K, Endogenous secretion of vascular endothelial growth factor by multipotent mesenchymal stromal cells derived from human third molar dental follicles//Cellular Transplantation and Tissue Engineering. - 2012. - Vol.7, Is.3. - P.155-158.
Events
2017
2016
Дистанционное образование
Метгенисслед_01-811-861
https://teams.microsoft.com/l/team/19%3a7GLrLoMYeNy3Se-WqCPeWHlB1ky_SrGXM1UGwHMVqYs1%40thread.tacv2/conversations?groupId=017688a9-fb6a-4cd5-aa6e-dd7e9dd339a0&tenantId=48b841f1-ebe6-4e30-b712-949430708487
Taught disciplines
| Discipline | Curriculum | Authors | File |
| Клиническая генетика | 31.05.03 Dentistry, Specialist Degree GP dentist (Стоматология) 2019 y. |
Ризванов А.А. Соловьева В.В. |
|
| Клиническая генетика | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2019 y. |
Ризванов А.А. Соловьева В.В. |
|
| Клиническая генетика | 31.05.03 Dentistry, Specialist Degree GP dentist (Стоматология) 2018 y. |
Ризванов А.А. Соловьева В.В. |
|
| Клиническая генетика | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2020 y. |
Ризванов А.А. Соловьева В.В. |
|
| Клиническая генетика | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2018 y. |
Ризванов А.А. Соловьева В.В. |
|
| Медицинская генетика | 30.05.01 Medical Biochemistry, Specialist Degree Biochemische Arzt (Медицинская биохимия) 2018 y. |
Ризванов А.А. Соловьева В.В. Габелко Д.И. |
|
| Медицинская генетика | 30.05.01 Medical Biochemistry, Specialist Degree Biochemische Arzt (Медицинская биохимия) 2020 y. |
Ризванов А.А. Соловьева В.В. Габелко Д.И. |
|
| Медицинская генетика | 30.05.01 Medical Biochemistry, Specialist Degree Biochemische Arzt (Медицинская биохимия) 2019 y. |
Ризванов А.А. Соловьева В.В. Габелко Д.И. |
|
| Медицинская генетика | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2018 y. |
Каюмов А.Р. Ризванов А.А. Соловьева В.В. Старостина И.Г. Габелко Д.И. |
|
| Медицинская генетика | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2020 y. |
Каюмов А.Р. Ризванов А.А. Соловьева В.В. Старостина И.Г. Габелко Д.И. |
|
| Медицинская генетика | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2019 y. |
Каюмов А.Р. Ризванов А.А. Соловьева В.В. Старостина И.Г. Габелко Д.И. |
|
| Медицинская генетика в стоматологии | 31.05.03 Dentistry, Specialist Degree GP dentist (Стоматология) 2017 y. |
Каюмов А.Р. Ризванов А.А. Соловьева В.В. Старостина И.Г. Габелко Д.И. |
|
| Медицинская генетика в стоматологии | 31.05.03 Dentistry, Specialist Degree GP dentist (Стоматология) 2018 y. |
Каюмов А.Р. Ризванов А.А. Соловьева В.В. Старостина И.Г. |
|
| Медицинская генетика в стоматологии | 31.05.03 Dentistry, Specialist Degree GP dentist (Стоматология) 2020 y. |
Каюмов А.Р. Ризванов А.А. Соловьева В.В. Старостина И.Г. |
|
| Медицинская генетика в стоматологии | 31.05.03 Dentistry, Specialist Degree GP dentist (Стоматология) 2019 y. |
Каюмов А.Р. Ризванов А.А. Соловьева В.В. Старостина И.Г. |
|
| Методы генетических исследований | 30.05.03 Medical Сybernetics, Specialist Degree Medical Kybernetiker (Медицинская кибернетика) 2020 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2023 y. |
Соловьева В.В. |
 |
| Методы генетических исследований | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2020 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 30.05.01 Medical Biochemistry, Specialist Degree Biochemische Arzt (Медицинская биохимия) 2022 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 31.05.01 General medicine , Specialist Degree General practitioner (Лечебное дело) 2022 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 30.05.01 Medical Biochemistry, Specialist Degree врач-биохимик (Медицинская биохимия) 2024 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 31.05.03 Dentistry, Specialist Degree GP dentist (Стоматология) 2022 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 30.05.01 Medical Biochemistry, Specialist Degree Biochemische Arzt (Медицинская биохимия) 2021 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 31.05.01 General medicine , Specialist Degree врач - лечебник (Лечебное дело) 2024 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 31.05.03 Dentistry, Specialist Degree GP dentist (Стоматология) 2023 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 31.05.03 Dentistry, Specialist Degree врач - стоматолог (Стоматология) 2024 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 30.05.01 Medical Biochemistry, Specialist Degree Biochemische Arzt (Медицинская биохимия) 2023 y. |
Соловьева В.В. |
|
| Методы генетических исследований | 30.05.02 Medical Biophysics , Specialist Degree Biophysische Arzt (Медицинская биофизика) 2020 y. |
Соловьева В.В. |
|
| Методы генетических исследований в фармации | 33.05.01 Pharmacy, Specialist Degree провизор (Фармация) 2024 y. |
Соловьева В.В. |
|
| Методы генетических исследований в фармации | 33.05.01 Pharmacy, Specialist Degree Apotheker (Фармация) 2021 y. |
Соловьева В.В. |
|
| Методы генетических исследований в фармации | 33.05.01 Pharmacy, Specialist Degree Apotheker (Фармация) 2020 y. |
Соловьева В.В. |
|
| Методы генетических исследований в фармации | 33.05.01 Pharmacy, Specialist Degree Apotheker (Фармация) 2023 y. |
Соловьева В.В. |
|
| Методы генетических исследований в фармации | 33.05.01 Pharmacy, Specialist Degree Apotheker (Фармация) 2022 y. |
Соловьева В.В. Гаранина Е.Е. |
|
| Work address: | 9 Parizhskoy Kommuny Str., Kazan, Academic and Research Centre of the Institute of Fundamental Medicine and Biology |
| Office number: | 323 |
| Phone: | 89196499343 |
| E-mail: | VaVSoloveva@kpfu.ru |
| VK: | https://vk.com/vespa |
| Google scholar: | https://scholar.google.ru/citations?hl=ru&user=dyWVwpYAAAAJ |
| Google+: | https://plus.google.com/+ЛерочкаСоловьёва |
| Experience: |
| Scientific and pedagogical experience: |
| General experience: |
| Experience in KFU: |